Serum-derived extracellular vesicles mediate Smad4 expression through shuttling microRNA-27a in the progression of laryngeal squamous cell carcinoma
- PMID: 35545731
- DOI: 10.1007/s13577-022-00712-6
Serum-derived extracellular vesicles mediate Smad4 expression through shuttling microRNA-27a in the progression of laryngeal squamous cell carcinoma
Abstract
Serum-derived extracellular vesicles (EVs) containing non-coding RNAs have been indicated to serve as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma (LSCC), while their functional role remains to be explored. Here, we summarize the possible mechanism explaining the laryngeal carcinogenesis and the associated changes with the involvement of extracellular microRNA (miR)-27a from serum of LSCC patients. Serum-derived EVs from LSCC patients were found to increase the proliferative activity and decreased the apoptotic activity of LSCC cells. miRNA microarrays revealed that miR-27a expression was elevated after EV treatment. miR-27a expression was elevated in LSCC tissues and predicted a poor prognosis for patients. Downregulation of miR-27a inhibited the effect of EVs to reduce the activity of LSCC cells in vitro and to suppress tumor development in vivo. miR-27a targeted SMAD family member 4 (Smad4) to mediate the Wnt/β-catenin pathway, which was induced under the influence of EVs. Smad4 was downregulated in LSCC tissues, and simultaneous overexpression of miR-27a and Smad4 resulted in reduced cell activity and tumorigenicity. In conclusion, serum-derived EVs support the laryngeal carcinogenesis at least partially via transferring miR-27a. miR-27a targets Smad4 and is a biomarker to predict LSCC prognosis.
Keywords: Extracellular vesicles; Laryngeal squamous cell carcinoma; Smad4; Wnt/β-catenin pathway; microRNA-27a.
© 2022. The Author(s) under exclusive licence to Japan Human Cell Society.
Similar articles
-
A Systematic Review of Circulating miRNAs Validated by Multiple Independent Studies in Laryngeal Cancer.Diagnostics (Basel). 2025 Feb 6;15(3):394. doi: 10.3390/diagnostics15030394. Diagnostics (Basel). 2025. PMID: 39941323 Free PMC article. Review.
-
Circ_0000218 plays a carcinogenic role in laryngeal cancer through regulating microRNA-139-3p/Smad3 axis.Pathol Res Pract. 2020 Sep;216(9):153103. doi: 10.1016/j.prp.2020.153103. Epub 2020 Jul 10. Pathol Res Pract. 2020. PMID: 32825967
-
MicroRNA-27a promotes proliferation and suppresses apoptosis by targeting PLK2 in laryngeal carcinoma.BMC Cancer. 2014 Sep 18;14:678. doi: 10.1186/1471-2407-14-678. BMC Cancer. 2014. PMID: 25239093 Free PMC article.
-
The knockdown of SNHG3 inhibits the progression of laryngeal squamous cell carcinoma by miR-340-5p/YAP1 axis and Wnt/β-catenin pathway.Neoplasma. 2020 Sep;67(5):1094-1105. doi: 10.4149/neo_2020_191022N1073. Epub 2020 Jun 16. Neoplasma. 2020. PMID: 32538668
-
Role and research progress of hematological markers in laryngeal squamous cell carcinoma.Diagn Pathol. 2023 Apr 20;18(1):50. doi: 10.1186/s13000-023-01335-7. Diagn Pathol. 2023. PMID: 37081512 Free PMC article. Review.
Cited by
-
A Systematic Review of Circulating miRNAs Validated by Multiple Independent Studies in Laryngeal Cancer.Diagnostics (Basel). 2025 Feb 6;15(3):394. doi: 10.3390/diagnostics15030394. Diagnostics (Basel). 2025. PMID: 39941323 Free PMC article. Review.
-
Extracellular Vesicles as Biomarkers in Head and Neck Squamous Cell Carcinoma: From Diagnosis to Disease-Free Survival.Cancers (Basel). 2023 Mar 17;15(6):1826. doi: 10.3390/cancers15061826. Cancers (Basel). 2023. PMID: 36980712 Free PMC article. Review.
-
Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review.Noncoding RNA. 2023 Jan 19;9(1):9. doi: 10.3390/ncrna9010009. Noncoding RNA. 2023. PMID: 36827542 Free PMC article. Review.
References
-
- Du L, Li H, Zhu C, Zheng R, Zhang S, Chen W. Incidence and mortality of laryngeal cancer in China, 2011. Chin J Cancer Res. 2015;27(1):52–8. https://doi.org/10.3978/j.issn.1000-9604.2015.02.02 . - DOI - PubMed - PMC
-
- Steuer CE, El-Deiry M, Parks JR, Higgins KA, Saba NF. An update on larynx cancer. CA Cancer J Clin. 2017;67(1):31–50. https://doi.org/10.3322/caac.21386 . - DOI - PubMed
-
- Jenckel F, Knecht R. State of the art in the treatment of laryngeal cancer. Anticancer Res. 2013;33(11):4701–10. - PubMed
-
- Li W, Chen Y, Nie X. Regulatory mechanisms of lncRNAs and their target gene signaling pathways in laryngeal squamous cell carcinoma. Front Pharmacol. 2020;11:1140. https://doi.org/10.3389/fphar.2020.01140 . - DOI - PubMed - PMC
-
- Tkach M, Thery C. Communication by extracellular vesicles: where we are and where we need to go. Cell. 2016;164(6):1226–32. https://doi.org/10.1016/j.cell.2016.01.043 . - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous